![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/05/04/2435635/0/en/Medolife-Rx-Schedules-Conference-Call-with-Investment-Community-to-Discuss-New-Updates-and-Answer-Questions.html
https://www.globenewswire.com/news-release/2022/02/07/2380048/0/en/Medolife-Rx-Announces-Changes-to-Management-and-Improvements-to-AELIA-s-Marketing-Efforts.html
https://www.globenewswire.com/news-release/2022/01/11/2364809/0/en/Medolife-Rx-Presents-Its-Venom-To-Drug-Development-Projects-at-an-International-Conference-Held-in-the-Dominican-Republic.html
https://www.globenewswire.com/news-release/2021/11/19/2338216/0/en/Medolife-Rx-Schedules-Conference-Call-with-Investment-Community-To-Discuss-Third-Quarter-2021-Financial-and-Operational-Results-and-New-Updates.html
https://www.globenewswire.com/news-release/2021/10/12/2312612/0/en/Medolife-Rx-Reports-257-Increase-in-Efficacy-of-Ibuprofen-Through-Proprietary-Polarization-Method-Looks-to-Expand-Into-Other-APIs.html
https://www.globenewswire.com/news-release/2021/10/06/2309562/0/en/Medolife-Rx-Initiates-Comparative-Study-of-Its-Flagship-CBD-based-Muscle-Rub-and-Competitor.html
https://www.globenewswire.com/news-release/2021/09/01/2290226/0/en/Medolife-Rx-Recaps-Successful-Attendance-at-Tony-Hawk-Event-Saw-Significant-Product-Exposure.html
https://finance.yahoo.com/news/medolife-rx-launches-pharmacokinetic-study-110000337.html
https://www.globenewswire.com/news-release/2021/07/29/2271133/0/en/Medolife-Rx-Cancels-Optional-Reverse-Split-Previously-Included-in-Filing.html
https://www.globenewswire.com/news-release/2021/07/21/2266666/0/en/Medolife-Rx-Schedules-Investor-Webcast-for-Tuesday-July-27-2021.html